A (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid DMF (Drug Master File) is a document detailing the whole manufacturing process of (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid active pharmaceutical ingredient (API) in detail. Different forms of (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid DMFs exist exist since differing nations have different regulations, such as (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid DMF submitted to regulatory agencies in the US is known as a USDMF. (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid USDMF includes data on (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid suppliers with USDMF on PharmaCompass.